Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

311 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Alternate Metabolic Programs Define Regional Variation of Relevant Biological Features in Renal Cell Carcinoma Progression.
Brooks SA, Khandani AH, Fielding JR, Lin W, Sills T, Lee Y, Arreola A, Milowsky MI, Wallen EM, Woods ME, Smith AB, Nielsen ME, Parker JS, Lalush DS, Rathmell WK. Brooks SA, et al. Among authors: rathmell wk. Clin Cancer Res. 2016 Jun 15;22(12):2950-9. doi: 10.1158/1078-0432.CCR-15-2115. Epub 2016 Jan 19. Clin Cancer Res. 2016. PMID: 26787754 Free PMC article.
Renal cell carcinoma.
Rathmell WK, Godley PA. Rathmell WK, et al. Curr Opin Oncol. 2004 May;16(3):247-52. doi: 10.1097/00001622-200405000-00010. Curr Opin Oncol. 2004. PMID: 15069321 Review.
Renal cell carcinoma.
Rathmell WK, Godley PA, Rini BI. Rathmell WK, et al. Curr Opin Oncol. 2005 May;17(3):261-7. doi: 10.1097/01.cco.0000155007.51495.d6. Curr Opin Oncol. 2005. PMID: 15818172 Review.
Molecularly targeted therapy in renal cell carcinoma.
Rathmell WK, Wright TM, Rini BI. Rathmell WK, et al. Expert Rev Anticancer Ther. 2005 Dec;5(6):1031-40. doi: 10.1586/14737140.5.6.1031. Expert Rev Anticancer Ther. 2005. PMID: 16336094 Review.
Renal cell carcinoma.
Rathmell WK, Martz CA, Rini BI. Rathmell WK, et al. Curr Opin Oncol. 2007 May;19(3):234-40. doi: 10.1097/CCO.0b013e3280ad4388. Curr Opin Oncol. 2007. PMID: 17414642 Review.
Neoadjuvant docetaxel/estramustine prior to radical prostatectomy or external beam radiotherapy in high risk localized prostate cancer: a phase II trial.
Kim WY, Whang YE, Pruthi RS, Baggstrom MQ, Rathmell WK, Rosenman JG, Wallen EM, Goyal LK, Grigson G, Watkins C, Godley PA. Kim WY, et al. Among authors: rathmell wk. Urol Oncol. 2011 Nov-Dec;29(6):608-13. doi: 10.1016/j.urolonc.2009.09.012. Epub 2009 Dec 21. Urol Oncol. 2011. PMID: 20022268 Clinical Trial.
311 results